Synonym: CGP 3466B; Dibenz[b,f]oxepin-10-methanamine, N-methyl-N-2-propyn-1-yl-, (2Z)-2-butenedioate (1:1); N-(Dibenz[b,f]oxepin-10-ylmethyl)-N-methyl-N-(2-propynyl)amine monomaleic acid salt; Omigapil maleate salt; TCH346
CAS Number: 200189-97-5
Empirical Formula (Hill Notation): C19H17NO · C4H4O4
Molecular Weight: 391.42
Linear Formula: C19H17NO · C4H4O4
Product Type: Chemical
This image is provided for informative purposes only and does not represent an actual product label. It should not be used as a substitute for official product labeling.
| assay |
≥98% (HPLC) |
| color |
white to beige |
| form |
powder |
| InChI |
1S/C19H17NO.C4H4O4/c1-3-12-20(2)14-16-13-15-8-4-6-10-18(15)21-19-11-7-5-9-17(16)19;5-3(6)1-2-4(7)8/h1,4-11,13H,12,14H2,2H3;1-2H,(H,5,6)(H,7,8)/b;2-1- |
| InChI key |
SQAZQLMBEHYFJA-BTJKTKAUSA-N |
| Quality Level |
100  |
| SMILES string |
N(CC1=Cc2c(cccc2)Oc3c1cccc3)(CC#C)C.OC(=O)C=C/C(=O)O |
| solubility |
DMSO: 2 mg/mL, clear |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
CGP3466B, also known as Omigapil maleate and TCH346, is a potent inhibitor of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). It has been shown to have neuroprotective activity and received U.S. FDA Fast Track Designation for the treatment of congenital muscular dystrophy in May 2016. |
| Biochem/physiol Actions: |
Inhibitor of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), neuroprotective. |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |